Kutatási jelek – Signal Engine

S2209: Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) — Multiple myeloma
New EASL Clinical Practice Guidelines on extrahepatic cholangiocarcinoma — Cholangiocarcinoma
Clinical trial: Esophageal Cancer, (NCT03081715) — Esophageal cancer
Scientists build cell line atlas of deadly cancers of the bile ducts and gallbladder — Cholangiocarcinoma
New prostate cancer treatments: Key physician takeaways — Prostate cancer
Decoding Clinical Trials in Metastatic Breast Cancer: Practical Insights for Optimal Therapy Sequencing — Breast cancer
Repurposed pinworm medication shows ‘promise’ as treatment for Merkel cell carcinoma — Merkel cell carcinoma
Phase 2b Trial for Cancer Vaccine in Newly Diagnosed Glioblastoma Will Continue — Glioblastoma
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) — Lymphoma
Merkel Cell Carcinoma Treatment Summary — Chronic lymphocytic leukemia
Blazing a Trail in Ph-ALL: Chemotherapy‑Free Options Gain Ground — Acute lymphoblastic leukemia
Bladder Cancer Treatment (PDQ®) – PDQ Cancer Information Summaries – NCBI Bookshelf — Bladder cancer
New CAR-T Therapy achieves positive results in a high proportion of patients with a refractory type of lymphoma — Hodgkin lymphoma
Perioperative Therapy in Oncogene-Driven NSCLC: Current Strategies and Unanswered Questions — NSCLC
Larotrectinib to Enhance RAI Avidity in Patients with Differentiated Thyroid Cancer Harboring NTRK fusions — Thyroid cancer
Research blog: Accelerating progress in AML — Acute myeloid leukemia
Clinical course of Merkel cell carcinoma: A DeCOG multicenter study of 1049 patients — Merkel cell carcinoma
When and How Long to Treat Chronic Lymphocytic Leukemia? — Chronic lymphocytic leukemia
Study Pinpoints Potential Ovarian Cancer Driver — Ovarian cancer
Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer — Uveal melanoma